BRAF and melanoma: Thus, the relatively non-cytotoxic group I specific PAK inhibitor, G-5555, almost completely canceled PAK signaling towards MEK1/2, but it had no effect on its own in suppressing the proliferation of BRAF V600-mutant melanoma cells under standard growth conditions.